Skip to main content
. 2015 Sep 11;10(9):e0137381. doi: 10.1371/journal.pone.0137381

Fig 4. Point-of-care activated clotting times (ACT) in whole blood from heparin-treated (control), ANV-6L15-treated and TAP-ANV-treated animals.

Fig 4

Blood was collected before (pre) and immediately after (post) AVG creation surgery. There was no significant difference between paired pre-operative and post-operative values in any group. The bars represent means ± SD.